These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9280299)

  • 1. Antioxidant role of melatonin in lipid peroxidation of human LDL.
    Abuja PM; Liebmann P; Hayn M; Schauenstein K; Esterbauer H
    FEBS Lett; 1997 Aug; 413(2):289-93. PubMed ID: 9280299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein.
    Yamamoto N; Moon JH; Tsushida T; Nagao A; Terao J
    Arch Biochem Biophys; 1999 Dec; 372(2):347-54. PubMed ID: 10600174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
    Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin related compounds inhibit lipid peroxidation during copper or free radical-induced LDL oxidation.
    Bonnefont-Rousselot D; Chevé G; Gozzo A; Tailleux A; Guilloz V; Caisey S; Teissier E; Fruchart JC; Delattre J; Jore D; Lesieur D; Duriez P; Gardès-Albert M
    J Pineal Res; 2002 Sep; 33(2):109-17. PubMed ID: 12153445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein.
    Halvorsen B; Brude I; Drevon CA; Nysom J; Ose L; Christiansen EN; Nenseter MS
    J Lipid Res; 1996 Jul; 37(7):1591-600. PubMed ID: 8827529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cu(I) availability paradoxically antagonizes antioxidant consumption and lipid peroxidation during the initiation phase of copper-induced LDL oxidation.
    Bagnati M; Bordone R; Perugini C; Cau C; Albano E; Bellomo G
    Biochem Biophys Res Commun; 1998 Dec; 253(2):235-40. PubMed ID: 9878521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant properties of butein isolated from Dalbergia odorifera.
    Cheng ZJ; Kuo SC; Chan SC; Ko FN; Teng CM
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):291-9. PubMed ID: 9630680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lag phase.
    Cadenas E; Sies H
    Free Radic Res; 1998 Jun; 28(6):601-9. PubMed ID: 9736312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and ex vivo inhibition of the modification of low-density lipoprotein by indapamide.
    Breugnot C; Iliou JP; Privat S; Robin F; Vilaine JP; Lenaers A
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):340-7. PubMed ID: 1279277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibition of lipid peroxidation.
    Tadolini B; Juliano C; Piu L; Franconi F; Cabrini L
    Free Radic Res; 2000 Jul; 33(1):105-14. PubMed ID: 10826926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein.
    Kontush A; Finckh B; Karten B; Kohlschütter A; Beisiegel U
    J Lipid Res; 1996 Jul; 37(7):1436-48. PubMed ID: 8827516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant effect of ethanol toward in vitro peroxidation of human low-density lipoproteins initiated by oxygen free radicals.
    Bonnefont-Rousselot D; Rouscilles A; Bizard C; Delattre J; Jore D; Gardès-Albert M
    Radiat Res; 2001 Feb; 155(2):279-87. PubMed ID: 11175662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation.
    Ito M; Murakami K; Yoshino M
    Food Chem Toxicol; 2005 Mar; 43(3):461-6. PubMed ID: 15680683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 17beta-estradiol and alpha-tocopherol on the oxidation of LDL cholesterol from postmenopausal women and the minor effect of gamma-tocopherol and melatonin.
    Arteaga E; Rojas A; Villaseca P; Bianchi M
    Menopause; 2000; 7(2):112-6. PubMed ID: 10746893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracetamol inhibits copper ion-induced, azo compound-initiated, and mononuclear cell-mediated oxidative modification of LDL.
    Nenseter MS; Halvorsen B; Rosvold O; Rustan AC; Drevon CA
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1338-44. PubMed ID: 7670947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methyl 9(or 10)-hydroxy-10(or 9)-mercaptostearate and hexadecanethioic S-acid on cupric ion- or 2,2-azo-bis(2-amidinopropane) dihydrochloride (AAPH)-induced oxidation of low density lipoprotein.
    Tanaka M; Takada K; Higuchi T; Nakagawa M; Murase M; Tobinaga S
    Biol Pharm Bull; 1996 May; 19(5):692-6. PubMed ID: 8741576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetradecylthioacetic acid and tetradecylselenoacetic acid inhibit lipid peroxidation and interact with superoxide radical.
    Muna ZA; Bolann BJ; Chen X; Songstad J; Berge RK
    Free Radic Biol Med; 2000 Apr; 28(7):1068-78. PubMed ID: 10832068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue.
    Iuliano L; Pedersen JZ; Camastra C; Bello V; Ceccarelli S; Violi F
    Free Radic Biol Med; 1999 Apr; 26(7-8):858-68. PubMed ID: 10232829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper can promote oxidation of LDL by markedly different mechanisms.
    Ziouzenkova O; Sevanian A; Abuja PM; Ramos P; Esterbauer H
    Free Radic Biol Med; 1998 Mar; 24(4):607-23. PubMed ID: 9559873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxazosin treatment and peroxidation of low-density lipoprotein among male hypertensive subjects: in vitro and ex vivo studies.
    Brude IR; Drevon CA; Viken K; Arnstad JE; Valnes KN; Nenseter MS
    Biochem Pharmacol; 1999 Jul; 58(1):183-91. PubMed ID: 10403533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.